Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more therapies

  • Technology appraisal guidance
  • TA669
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance 852.